tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Ratios

Compare
350 Followers

Keros Therapeutics Ratios

KROS's free cash flow for Q3 2025 was $0.97. For the 2025 fiscal year, KROS's free cash flow was decreased by $ and operating cash flow was $-0.61. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
29.86 14.25 17.27 21.23 37.27
Quick Ratio
29.86 14.25 17.32 20.97 37.06
Cash Ratio
28.78 13.59 16.86 19.42 37.01
Solvency Ratio
1.68 -4.02 -3.51 -4.79 -5.80
Operating Cash Flow Ratio
3.69 -5.11 -4.23 -5.25 -5.14
Short-Term Operating Cash Flow Coverage
38.30 0.00 -153.98 -72.10 -87.22
Net Current Asset Value
$ 680.10M$ 309.48M$ 256.41M$ 239.36M$ 260.00M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.04 0.04 <0.01 <0.01
Debt-to-Equity Ratio
0.02 0.04 0.05 <0.01 <0.01
Debt-to-Capital Ratio
0.02 0.04 0.05 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.02 0.00 0.04 <0.01 <0.01
Financial Leverage Ratio
1.06 1.11 1.11 1.05 1.03
Debt Service Coverage Ratio
29.60 0.00 -226.02 -67.42 -104.31
Interest Coverage Ratio
0.00 0.00 -114.79K -14.09K -7.78K
Debt to Market Cap
0.02 0.00 0.01 <0.01 <0.01
Interest Debt Per Share
0.43 0.49 0.53 0.05 0.06
Net Debt to EBITDA
-8.98 2.08 2.58 4.06 5.90
Profitability Margins
Gross Profit Margin
99.56%-439.74%0.00%95.53%0.00%
EBIT Margin
32.81%-101319.21%0.00%-282.23%0.00%
EBITDA Margin
30.52%-100779.47%0.00%-280.46%0.00%
Operating Profit Margin
17.67%-112543.71%0.00%-280.46%0.00%
Pretax Profit Margin
28.84%-101319.21%0.00%-282.25%0.00%
Net Profit Margin
26.12%-101319.21%0.00%-292.26%0.00%
Continuous Operations Profit Margin
26.12%-101319.21%0.00%-292.26%0.00%
Net Income Per EBT
90.59%100.00%100.00%103.54%99.62%
EBT Per EBIT
163.24%90.03%91.19%100.64%97.59%
Return on Assets (ROA)
8.68%-41.35%-34.12%-23.01%-16.84%
Return on Equity (ROE)
9.51%-46.05%-37.73%-24.16%-17.33%
Return on Capital Employed (ROCE)
6.06%-49.17%-39.55%-23.16%-17.79%
Return on Invested Capital (ROIC)
5.48%-49.02%-39.43%-23.81%-17.67%
Return on Tangible Assets
8.68%-41.35%-34.12%-23.01%-16.84%
Earnings Yield
9.13%-13.07%-8.64%-4.30%-4.15%
Efficiency Ratios
Receivables Turnover
70.65 0.14 0.00 1.12 0.00
Payables Turnover
0.63 0.15 0.48 0.25 0.28
Inventory Turnover
0.00 0.00 -1.92 0.29 0.41
Fixed Asset Turnover
11.20 <0.01 0.00 8.37 0.00
Asset Turnover
0.33 <0.01 0.00 0.08 0.00
Working Capital Turnover Ratio
0.35 <0.01 0.00 0.08 0.00
Cash Conversion Cycle
-576.91 196.39 -944.71 88.27 -407.23
Days of Sales Outstanding
5.17 2.64K 0.00 326.87 0.00
Days of Inventory Outstanding
0.00 0.00 -190.07 1.24K 889.27
Days of Payables Outstanding
582.07 2.44K 754.63 1.48K 1.30K
Operating Cycle
5.17 2.64K -190.07 1.57K 889.27
Cash Flow Ratios
Operating Cash Flow Per Share
2.19 -4.23 -2.78 -2.66 -2.38
Free Cash Flow Per Share
2.14 -4.31 -2.82 -2.71 -2.40
CapEx Per Share
0.04 0.08 0.05 0.04 0.02
Free Cash Flow to Operating Cash Flow
0.98 1.02 1.02 1.02 1.01
Dividend Paid and CapEx Coverage Ratio
52.05 -50.53 -56.46 -60.69 -125.49
Capital Expenditure Coverage Ratio
52.05 -50.53 -56.46 -60.69 -125.49
Operating Cash Flow Coverage Ratio
5.09 -8.62 -5.28 -56.86 -41.04
Operating Cash Flow to Sales Ratio
0.36 -824.56 0.00 -3.09 0.00
Free Cash Flow Yield
12.37%-10.84%-5.88%-4.63%-3.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.95 -7.65 -11.58 -23.24 -24.11
Price-to-Sales (P/S) Ratio
2.85 7.75K 0.00 67.92 0.00
Price-to-Book (P/B) Ratio
1.00 3.52 4.37 5.61 4.18
Price-to-Free Cash Flow (P/FCF) Ratio
8.09 -9.22 -17.00 -21.61 -29.41
Price-to-Operating Cash Flow Ratio
7.95 -9.40 -17.30 -21.97 -29.65
Price-to-Earnings Growth (PEG) Ratio
0.02 -0.30 -0.18 1.66 -0.22
Price-to-Fair Value
1.00 3.52 4.37 5.61 4.18
Enterprise Value Multiple
0.37 -5.61 -9.18 -20.16 -18.45
Enterprise Value
28.11M 854.11M 946.29M 1.14B 828.84M
EV to EBITDA
0.37 -5.61 -9.18 -20.16 -18.45
EV to Sales
0.11 5.66K 0.00 56.53 0.00
EV to Free Cash Flow
0.32 -6.73 -13.27 -17.99 -22.29
EV to Operating Cash Flow
0.32 -6.86 -13.51 -18.28 -22.47
Tangible Book Value Per Share
17.32 11.28 10.99 10.42 16.88
Shareholders’ Equity Per Share
17.32 11.28 10.99 10.42 16.88
Tax and Other Ratios
Effective Tax Rate
0.09 0.00 >-0.01 -0.04 <0.01
Revenue Per Share
6.07 <0.01 0.00 0.86 0.00
Net Income Per Share
1.59 -5.20 -4.15 -2.52 -2.93
Tax Burden
0.91 1.00 1.00 1.04 1.00
Interest Burden
0.88 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.64 895.75 0.00 2.74 0.00
SG&A to Revenue
0.19 230.69 0.00 1.06 0.00
Stock-Based Compensation to Revenue
0.12 190.48 0.00 0.58 0.00
Income Quality
1.38 0.81 0.67 1.06 0.81
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis